Levetiracetam Docgen (Levetiracetam)

Levetiracetam is an antiepileptic medication used to manage seizure disorders.

• Partial‑onset seizures: reduces seizure frequency and severity in patients with focal epilepsy.
• Generalized tonic‑clonic seizures: helps control convulsive episodes in generalized epilepsy.
• Myoclonic seizures: decreases myoclonic jerks in patients with juvenile myoclonic epilepsy.

• Levetiracetam binds to the synaptic vesicle protein SV2A, modulating neurotransmitter release and stabilizing neuronal membranes. This interaction reduces synaptic transmission of excitatory signals, thereby decreasing neuronal hyperexcitability that underlies seizure activity. The precise downstream effects involve inhibition of calcium‑dependent release of glutamate, contributing to its antiepileptic properties. Additionally, levetiracetam may influence GABAergic pathways and attenuate abnormal neuronal firing patterns, further supporting seizure control.

Levetiracetam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Dizziness: sensation of light‑headedness or unsteadiness, often transient.
• Fatigue: feeling unusually tired or weak, may affect daily activities.
• Headache: mild to moderate cranial pain, sometimes worsens with stress.
• Irritability: increased mood swings or agitation, reported especially in younger patients.
• Nausea: upset stomach or urge to vomit, usually mild.
• Somnolence: excessive sleepiness or drowsiness during the day.
• Coordination problems: clumsiness, tremor, or difficulty with fine motor tasks.

Serious or Rare Side Effects

• Severe allergic reaction: rash, swelling, or difficulty breathing requiring immediate medical attention.
• Mood or behavior changes: depression, suicidal thoughts, aggression, or hostility that may emerge suddenly.
• Blood disorders: low white blood cell (leukopenia) or platelet (thrombocytopenia) counts, increasing infection or bleeding risk.

When prescribing levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

• Renal function: adjust dose in patients with impaired kidney function.
• Psychiatric history: monitor for mood changes, depression, or suicidal ideation.
• Concomitant CNS depressants: use caution as combined effects may increase sedation.
• Pregnancy: evaluate risk‑benefit ratio; limited data available.
• Driving and machinery: advise patients to assess personal response before operating vehicles.
• Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Levetiracetam can interact with other medicines, influencing its effectiveness or safety profile.

Major Interactions (Avoid)

• Carbamazepine: may reduce levetiracetam plasma levels, decreasing efficacy.
• Phenobarbital: may lower levetiracetam concentrations, requiring monitoring.
• Rifampin: induces metabolism, potentially decreasing levetiracetam exposure.

Moderate Interactions (Monitor Closely)

• Alcohol: can enhance central nervous system depression, increasing dizziness or drowsiness.
• Other antiepileptics (e.g., valproate, phenytoin): may require dose adjustments based on therapeutic monitoring.
• Oral contraceptives: levetiracetam may slightly reduce hormonal contraceptive effectiveness.